Found 42 matching trials
ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer PHASE1 This is a single-arm, multicenter, phase II study designed to evaluate the ...
Show More Location
Multiple Locations
Learn More & Join Trial
Prospective, Open-label, Multi-cohort Study of Becotatug Vedotin With Tislelizumab and Chemotherapy in Esophageal Squamous Cell Carcinoma - Phase 2 PHASE2 Esophageal squamous cell carcinoma (ESCC) is a common malignant tumor world...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
ADC and SBRT for Recurrent/Metastatic Salivary Gland Carcinoma PHASE2 This is a single-arm, single-center, exploratory clinical study. The study ...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Pucotenlimab and Becotatug Vedotin for Locally Advanced Penile Cancer PHASE2 This is an open-label, multicenter, single-arm Phase 2 clinical trial evalu...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Becotatug Vedotin Plus Pucotenlimab for Advanced Biliary Tract Cancer, Phase II PHASE2 Biliary tract carcinoma (BTC), including cholangiocarcinoma and gallbladder...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase II Study of Becotatug Vedotin Plus Pucotenlimab for Advanced Refractory Solid Tumors With EGFR-Positive PHASE2 This phase II trial evaluates the combination of Becotatug Vedotin (MRG003)...
Show More Location
Tianjin Medical Unversity Second Hospital
Learn More & Join Trial
Neoadjuvant Presurgical Becotatug Vedotin (MRG003) Plus Pucotenlimab (HX008) in Oral Cavity Squamous Cell Carcinoma PHASE2 This is a phase 2, open-label, single-arm clinical trial evaluating neoadju...
Show More Location
Hospital of Stomatology, Sun Yat-sen University
Learn More & Join Trial
A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer PHASE2 This is a prospective, multicenter, single-arm clinical trial investigating...
Show More Location
Union Hospital, Huazhong University of Science and Technology
Learn More & Join Trial
Becotatug Vedotin Plus Tislelizumab and Low-Dose Lenvatinib for Advanced Esophageal Squamous Cell Carcinoma, Phase II PHASE2 Immunotherapy combined with chemotherapy has become the first-line standard...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors PHASE1 There is a significant unmet medical need for effective therapies for pedia...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial